Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
Coverage of Sarepta Duchenne drug may be halted by N.Y. state Medicaid
In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…
Patient groups cheer as the WHO adds diabetes and cystic fibrosis drugs to its essential medicines list
For the first time, the World Health Organization has added various high-cost treatments for diabetes and cystic fibrosis…
US drug pricing shake-up threatens access to medicines in Europe – POLITICO
For European drugmakers there are still many unknowns about how the MFN scheme — and overall tariffs on…